Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

Clinical trial NCT05000294 · RECRUITING

Trial details

NCT number: NCT05000294
Sponsor: University of Florida
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Bile Duct Cancer Gall Bladder Cancer Breast Cancer Neuroendocrine Tumors Ovarian Cancer Pancreatic Adenocarcinoma Soft Tissue Sarcoma Vulvar Cancer Prostate Cancer

Start date: 2021-12-07
Primary completion: 2026-12-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.